The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer, according to researchers.
This is a discussion on Two-drug phase I trial shows promise in treating late-stage ovarian cancer within the Medical News forums, part of the More category; The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer, according to ...
The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer, according to researchers.